Showing results (4281-4290 of 6,795) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|August 6, 2011
Pitavastatin calcium: clinical review of a new antihyperlipidemic medicationLaurie L Yee, Eric A Wright
Clinical Therapeutics|August 6, 2011
Comparison of antiplatelet effect and tolerability of clopidogrel resinate with clopidogrel bisulfate in patients with coronary heart disease (CHD) or CHD-equivalent risks: a phase IV, prospective, double-dummy, parallel-group, 4-week noninferiority trialJung-Won Suh, Ki-Bae Seung, Chung-Hwan Gwak, et al.
Clinical Therapeutics|January 31, 2012
Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysisLenard A Adler, Timothy Wilens, Shuyu Zhang, et al.
Clinical Therapeutics|July 1, 1990
Choosing a target for cognitive enhancersH Allain, D Bentué-Ferrer, R Decombe
Clinical Therapeutics|July 1, 1990
Inhibitory effects of ulinastatin on the production of cytokines: implications for the prevention of septicemic shockS Endo, K Inada, K Taki, et al.
Clinical Therapeutics|July 1, 1990
Evaluation of IPM/CS in gram-negative bacillus infections: use of an endotoxin-specific assayS Endo, K Inada, Y Inoue, et al.
Clinical Therapeutics|January 17, 2012
Intra-anal Iferanserin 10 mg BID for hemorrhoid disease: a prospective, randomized, double-blind, placebo-controlled trialAlexander Herold, John Dietrich, Roger Aitchison
Clinical Therapeutics|January 17, 2012
Metabolism, excretion, and pharmacokinetics of [14c]-radiolabeled aleglitazar: a phase I, nonrandomized, open-label, single-center, single-dose study in healthy male volunteersStefan Sturm, Michael Seiberling, Idelette Weick, et al.
Clinical Therapeutics|March 27, 2012
Network analysis of randomized controlled trials in multiple sclerosisElias Zintzaras, Chrysoula Doxani, Theodoros Mprotsis, et al.
Clinical Therapeutics|December 20, 2011
Comparison of Murraya koenigii- and Tribulus terrestris-based oral formulation versus tamsulosin in the treatment of benign prostatic hyperplasia in men aged >50 years: a double-blind, double-dummy, randomized controlled trialGairik Sengupta, Avijit Hazra, Anup Kundu, et al.
Pageof 680